Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 2/20 | 0.71 |
| ▸ | PTGES | O14684 | 1/20 | 0.49 |
| ▸ | ACLY | P53396 | 1/20 | 0.46 |
| ▸ | ACACA | Q13085 | 1/20 | 0.46 |
| ▸ | EBP | Q15125 | 4/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | PRKAG1 | P54619 | 8/20 | 0.42 |
| ▸ | PRKAA2 | P54646 | 8/20 | 0.42 |
| ▸ | PRKAB1 | Q9Y478 | 8/20 | 0.42 |
| ▸ | CRYAB | P02511 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9766794 | 0.91 | HMGCR (0.71) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9766787 | 0.91 | HMGCR (0.71) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9766763 | 0.86 | HMGCR (0.73) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9766767 | 0.86 | HMGCR (0.73) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL13384620 | 0.85 | HMGCR (0.79) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9766761 | 0.83 | HMGCR (0.74) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9766765 | 0.83 | HMGCR (0.74) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9644097 | 0.83 | HMGCR (0.51) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9769589 | 0.78 | HMGCR (0.69) | HMGCRPTGESACLYACACAEBP | |
| SCHEMBL9769631 | 0.78 | HMGCR (0.69) | HMGCRPTGESACLYACACAEBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0276823-B1 | 14,15-SUBSTITUTED LANOSTEROLS AND THEIR USE AS HYPOCHOLESTEROLEMIC AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-09-23 | — | — | EP | disclosed |
| US-5041432-A | Enzyme inhibitors | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-08-20 | — | — | US | disclosed |
| US-5034548-A | Enzyme inhibitors for reducing serum cholesterol | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-07-23 | — | — | US | disclosed |
| EP-0276823-A2 | 14,15-Substituted lanosterols and their use as hypocholesterolemic agents | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1988-08-03 | — | — | EP | disclosed |